<DOC>
	<DOC>NCT00296387</DOC>
	<brief_summary>The purpose of this study is to see if rosuvastatin compared to Atorvastatin is effective in treating ACS by decreasing the ApoB/ApoA-1 ratio and if starting statin within 24 h following the onset of the first symptoms is beneficial compared to placebo.</brief_summary>
	<brief_title>Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Hospital admission for ACS with chest pain or discomfort occurring during rest or with minimal exertion, Percutaneous coronary intervention (PCI) planned, Evidence of coronary artery disease Hypersensitivity to statins Any cholesterol lowering medication taken within 1 month prior V1 Sustained STsegment elevation on ECG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>